Search Results
Jul 10, 2025, 08:03 ET UMHS Launches UWorld-Backed Curriculum, Leading the Caribbean in Student-Focused Innovation
enhanced Clinical Science Program in Maine. Starting this September, access will expand to include students in EBS 5 and Med 4 in St. Kitts, with plans to embed UWorld resources throughout the Basic Science curriculum. This initiative
More news about: University of Medicine and Health Sciences, St. Kitts
Jul 10, 2025, 08:00 ET Synchrony Medical Receives 510(k) FDA Clearance for LibAirty™ Airway Clearance System for At-Home Respiratory Relief
https://libairty.health. Helper N, Ashkenazi M, Sokol G, Dagan A, Efrati O. A Novel Medical Device for Airway Clearance. J Clin Med. 2025 Jan 30;14(3):907.Mingora C, Barfield W, Shani A, Tzfoni T, Flume P. Evaluation of the Safety and Efficacy of LibAirty™ Airway
More news about: Synchrony Medical
Jul 10, 2025, 05:00 ET Kognitiv förvärvar ClouDevOps för att stärka support av Workday i Europa
närvarande över 400 Workday-klienter med en portfolio som består av globala storföretag, bland andra Spotify, Finastra och nCino, genom att utveckla och integrera Workdays HCM- och Financial Management-plattformar mer strategiskt och effektivt över deras organisationer. Med detta senaste förvärv så kommer
More news about: Kognitiv Inc
Jul 10, 2025, 02:36 ET Vantage dominerar Online Money Awards 2025 med utmärkelserna för bästa multitillgångsmäklare och bästa kundtjänst
Online Money Awards gör att vi kan hålla nära kontakt med de allra bästa på marknaden." Med dessa senaste framgångar stärker Vantage sin position som en tillförlitlig partner för handlare globalt genom att kombinera olika tillgångserbjudanden med exceptionell kundtjänst. Besök
More news about: Vantage
Jul 09, 2025, 18:53 ET Johnson & Johnson、アジア太平洋地域にVARIPULSE™プラットフォームを導入、心房細動治療の進歩に貢献
Anter、E.、Mansour、M.、Nair、D.G.他。持続性心房細動に対するデュアルエネルギー格子チップ・アブレーション・システム：ランダム化試験。Nat Med 30, 2303–2310 (2024). https://doi.org/10.1038/s41591-024-03022-6 pg 2
More news about: Johnson & Johnson MedTech
Jul 09, 2025, 16:00 ET Taiho Oncology and Taiho Pharmaceutical Announce U.S. FDA Acceptance of Supplemental New Drug Application for INQOVI® in Combination with Venetoclax to Treat Patients with Acute Myeloid Leukemia
Rojas C, et al. Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase. J Med Chem 2014; 57:2582-2588.Contacts Taiho Oncology Leigh Labrie(609) 664-9878
More news about: Taiho Oncology
Jul 09, 2025, 12:57 ET The Inner Circle acknowledges, Frank Tortorice, MD, ABIM, IFMCP as a Pinnacle Lifetime Member
Psychology from San Jose State University before pursuing his Doctor of Medicine at the University Di Roma-La Sapienza, Fac Di Med E Chirurgia in Rome. He completed his internal medicine and pediatrics residency at the Western Reserve Case System
More news about: The Inner Circle
Jul 09, 2025, 09:57 ET Johnson & Johnson Luncurkan VARIPULSE™ Platform di Asia Pasifik Untuk Memajukan Pengobatan Fibrilasi Atrium
Mansour, M., Nair, D.G. dkk. Sistem ablasi dengan ujung berbentuk kisi dan energi ganda untuk fibrilasi atrium persisten: uji coba secara acak. Nat Med 30, 2303–2310 (2024). https://doi.org/10.1038/s41591-024-03022-6 Hal. 2
More news about: Johnson & Johnson MedTech
Jul 09, 2025, 09:26 ET Landmark Study Shows Ultromics' EchoGo® Amyloidosis Significantly Improves Detection of Cardiac Amyloidosis with Echocardiography
et al., JACC Heart Fail. 2020;8:712–24.[4] AbouEzzeddine OF, et al., JAMA Cardiol. 2021;6:1267–74.[5] Maurer MS, et al., N Engl J Med 2018;379:1007–16.[6] Hahn VS et al, JACC Heart Fail. 2020;8:712–724. Photo:
More news about: Ultromics
Jul 08, 2025, 13:28 ET Street Water Capital taler ut om siste oppdatering fra REC Silicons styre
farlige situasjonen. Den samme aksjonæren gikk med på å finansiere selskapet i TA, men trakk så tilbake dette løftet da den mistet kontrollen over styret. Water Street mener at denne handlingen er et materielt brudd på TA under amerikansk lov. Med tanke på muligheten til å bringe eiendelene til
More news about: Water Street Capital, Inc.
Jul 08, 2025, 12:11 ET 존슨앤드존슨, 아시아 태평양 지역에서 베리펄스™ 플랫폼 출시로 심방세동 치료 혁신 선도
Anter, E., Mansour, M., Nair, D.G. et al. Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial. Nat Med 30, 2303–2310 (2024). https://doi.org/10.1038/s41591-024-03022-6 pg 2
More news about: Johnson & Johnson MedTech
Jul 08, 2025, 10:51 ET Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval
December 2022. 2Haik H, et al. Population-Based Trends in Complexity of Hospital Inpatients JAMA Intern Med. 2024;184(2):183-192. doi:10.1001/jamainternmed.2023.7410
More news about: Cerapedics Inc.
Jul 08, 2025, 10:12 ET Pyramid Educational Consultants to Host Virtual "Pyramid FUNctional Conference 2025: Shaping Tomorrow's Success Today" on October 14, 2025
in the community." – Dr. Bondy Additional featured speakers include: Armando Bernal, MEd, BCBA, a neurodivergent behavior analyst and founder of Autism International Consulting, a self-advocacy-centered organization which provides in-home
More news about: Pyramid Educational Consultants
Jul 08, 2025, 09:00 ET MediView Announces Launch of Multicenter Study Validating XR90 Surgical Navigation for Soft Tissue Biopsy
support interventional radiology practices." About MediView MediView is a Cleveland, OH based med-tech company working to advance human health through its digital augmented reality ecosystem. MediView's intuitive augmented reality visualization platform
More news about: MediView XR, Inc.
Jul 08, 2025, 08:00 ET ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
ProPharmaFor more than 20 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise
More news about: ProPharma Group Holdings LLC
Jul 08, 2025, 08:00 ET Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo
iv Lafeuille MH, Gravel J, Lefebvre P, et al. Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics. J Med Econ. 2013;16(11):1290-1299. doi: 10.3111/13696998.2013.841705 v Birchwood, M. "Early intervention and sustaining the management
More news about: Johnson & Johnson
Jul 08, 2025, 07:37 ET Cochlear Launches World's First and Only Smart Cochlear Implant System
2023. 028-Q048-02 Rev D. Advanced Bionics AG and affiliates.; 2023.12 MED-EL Cochlear Implant Systems Reliability Report April 2023. M00815 r3.0. MED-EL Medical Electronics.; 2023.13 Cochlear Limited D1980144 CP1110 IEC60529 IP68
More news about: Cochlear North America
Jul 08, 2025, 07:00 ET UCB extends its BIMZELX® "Get Yourself Back" direct-to-consumer campaign for the hidradenitis suppurativa community
controlled, multicentre Phase 3 trials. Lancet. 2024;403(10443):2504-19.Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158-164.Sabat R, Jemec GBE, Matusiak L, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18.Lee
More news about: UCB
Jul 08, 2025, 03:30 ET Neuraxpharm and Dizlin Pharmaceuticals Announce Global Strategic Co-Development Agreement Bringing Next-Generation Drug-Device Therapy to Patients with Advanced Parkinson's Disease
Legacy of InnovationThis agreement builds on Neuraxpharm's expanding portfolio of strategic alliances that bridge pharmaceutical and med-tech innovation. It follows the Company's entry into digital health through the commercialisation agreement with mjn-neuro in 2022 for a wearable device
More news about: Neuraxpharm
Jul 07, 2025, 19:29 ET Hypershell reflekterer over en inspirerende helg etter fremvisning av Carbon X under Tokyo Outdoor Show 2025
MotionEngine. Carbon X veier kun 1,8 kg med en sammenleggbar konstruksjon, og har en rekkevidde på 17,5 km per batteri, 30 %redusert fysisk anstrengelse og opptil 40 % økt benstyrke. Den er også bygget for å tåle det ekstreme; med en IP54-rangering og drift ned til -20
More news about: Hypershell Co., Ltd.
Jul 07, 2025, 19:05 ET Hypershell reflects on an inspiring weekend showcasing Carbon X at Tokyo udendørs show 2025
sammen. Den har en rækkevidde på 17,5 km pr. batteri, reducerer den fysiske anstrengelse med 30 % og øger benstyrken med op til 40 %. Den er bygget til at modstå ekstreme forhold med en IP54-klassificering og drift ned til -20 °C, og den er også ekstremt holdbar takket
More news about: Hypershell Co., Ltd.
Jul 07, 2025, 18:51 ET Hypershell reflekterar över en inspirerande helg då man visade upp Carbon X på Tokyo Outdoor Show 2025
MotionEngine. Carbon X väger bara 1,8 kg med en hopvikbar konstruktion och erbjuder 17,5 km räckvidd per batteri, minskad fysisk ansträngning med 30 % och ökad benstyrka med upp till 40 %. Den är byggd för att klara extrema förhållanden med IP54-värde och drift ner till -20
More news about: Hypershell Co., Ltd.
Jul 07, 2025, 10:00 ET Estudos globais de fase III demonstram que nerandomilaste retardou o declínio da função pulmonar em FPI e FPP, com taxas de descontinuação semelhantes às do placebo
Referências: Richeldi L, Azuma A, Cottin V, et al. Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis. N Engl J Med. 2025 May 18. doi: 10.1056/NEJMoa2414108. Online ahead of print. Disponível em:
More news about: Boehringer Ingelheim
Jul 04, 2025, 05:22 ET Vantage Markets fejrer pris og succesfuld debut på Wealth Expo Peru 2025
brancheanerkendelse til dynamiske samtaler med samfundet gav Wealth Expo Peru værdifuld indsigt i dette dynamiske finansielle miljø. Vi ser frem til fortsat at støtte finansiel uddannelse og innovation i handelssamfundet." Mens Vantage fortsætter med at samarbejde med finansverdenen globalt, er firmaet
More news about: Vantage
Jul 04, 2025, 05:05 ET Vantage brillerer på Money Expo Colombia 2025 med brancheanerkendelse og dynamisk engagement
Vantage Markets (eller Vantage) er en CFD-mægler med flere aktiver, der giver kunderne adgang til en smidig og effektiv tjeneste til handel med differencekontrakter (CFD'er), herunder valuta, råvarer, indekser, aktier, ETF'er og obligationer. Med over 15 års erfaring på markedet går Vantage ud
More news about: Vantage